Media Summary: Professor Ashwini Nangia, Chemistry Department, University of Hydearabad, India. This is part of SSPC's research bytes from our PhD and Postdoctoral researchers in each of our 5 research themes: Molecules I, II, ... Pharmaceutical polymorph and co-crystal screening

Polymorphs And Cocrystals In Pharmaceutical Development - Detailed Analysis & Overview

Professor Ashwini Nangia, Chemistry Department, University of Hydearabad, India. This is part of SSPC's research bytes from our PhD and Postdoctoral researchers in each of our 5 research themes: Molecules I, II, ... Pharmaceutical polymorph and co-crystal screening Poorly soluble crystalline small molecules pose a challenge during Holodiag performs solid state studies of small organic molecules to identify new solid forms such as Welcome to Solid State Foundations Chapter 1! In this first installment, Clara Pina Coronado takes us through the very first ...

Photo Gallery

Polymorphs and cocrystals in pharmaceutical development
Revealing the mysteries of pharmaceutical co-crystals
Solid State Foundations | Chapter 5: Salts and Cocrystals
W6L29_Case Studies on Polymorphism, Cocrystallization, Applications to Pharmaceutical Cocrystals
Dr Sarah Guerin, UL: Predictive Design of Pharmaceutical Cocrystals
Pharmaceutical polymorph and co-crystal screening
Solid State Foundations | Chapter 11: Where To Start With Solid Form
Dr. Karthik Nagapudi - Mechanochemical Synthesis and Scale up of Pharmaceutical Cocrystals
Research Presentation - CoCrystal Pharma COCP [ENG]
Polymorphism in Pharmaceuticals Part I
Holodiag, your expert CRO for polymorphs, cocristals and salts screenings
ART12.11: The advantages of a CBD Cocrystal
Sponsored
View Detailed Profile
Polymorphs and cocrystals in pharmaceutical development

Polymorphs and cocrystals in pharmaceutical development

Professor Ashwini Nangia, Chemistry Department, University of Hydearabad, India.

Revealing the mysteries of pharmaceutical co-crystals

Revealing the mysteries of pharmaceutical co-crystals

Have you ever wondered what

Solid State Foundations | Chapter 5: Salts and Cocrystals

Solid State Foundations | Chapter 5: Salts and Cocrystals

Salts vs

W6L29_Case Studies on Polymorphism, Cocrystallization, Applications to Pharmaceutical Cocrystals

W6L29_Case Studies on Polymorphism, Cocrystallization, Applications to Pharmaceutical Cocrystals

Salt-

Dr Sarah Guerin, UL: Predictive Design of Pharmaceutical Cocrystals

Dr Sarah Guerin, UL: Predictive Design of Pharmaceutical Cocrystals

This is part of SSPC's research bytes from our PhD and Postdoctoral researchers in each of our 5 research themes: Molecules I, II, ...

Sponsored
Pharmaceutical polymorph and co-crystal screening

Pharmaceutical polymorph and co-crystal screening

Pharmaceutical polymorph and co-crystal screening

Solid State Foundations | Chapter 11: Where To Start With Solid Form

Solid State Foundations | Chapter 11: Where To Start With Solid Form

Polymorph

Dr. Karthik Nagapudi - Mechanochemical Synthesis and Scale up of Pharmaceutical Cocrystals

Dr. Karthik Nagapudi - Mechanochemical Synthesis and Scale up of Pharmaceutical Cocrystals

Poorly soluble crystalline small molecules pose a challenge during

Research Presentation - CoCrystal Pharma COCP [ENG]

Research Presentation - CoCrystal Pharma COCP [ENG]

Research Presentation -

Polymorphism in Pharmaceuticals Part I

Polymorphism in Pharmaceuticals Part I

Polymorphism

Holodiag, your expert CRO for polymorphs, cocristals and salts screenings

Holodiag, your expert CRO for polymorphs, cocristals and salts screenings

Holodiag performs solid state studies of small organic molecules to identify new solid forms such as

ART12.11: The advantages of a CBD Cocrystal

ART12.11: The advantages of a CBD Cocrystal

Artelo Biosciences

Solid State Foundations | Chapter 1: Amorphous vs. Crystalline & Polymorphism

Solid State Foundations | Chapter 1: Amorphous vs. Crystalline & Polymorphism

Welcome to Solid State Foundations Chapter 1! In this first installment, Clara Pina Coronado takes us through the very first ...